|Previous Section||Index||Home Page|
Mr. Willetts: To ask the Secretary of State for Work and Pensions what plans he has for a further promotional campaign on stakeholder pensions; and what provision for such a campaign has been included in the previously announced forecasts of current year spending. 
16 Jul 2001 : Column: 64W
about the range of pension options available, including stakeholder pensions. Our activities to inform employers about stakeholder pensions began last autumn when we mailed all employers with five or more employees and a programme of media activity has been taking place since then. In addition, we will be mailing employers with five or more employees again shortly to remind them about stakeholders.
Mr. McCartney: The Social Security Agreement between the UK and Australia ended on 28 February 2001. The Government announced in December that the UK pension position of people who had lived in Australia when the Agreement was in force would be protected. The Agreement allowed residence in Australia to count towards the UK retirement pension of people living in the UK. Periods of residence in Australia, up to 5 April 2001, can still be used in the pension calculation for people living permanently in the UK when they retire.
Lynne Jones: To ask the Secretary of State for Work and Pensions what monitoring has taken place of the schemes piloting compulsory interviews for (a) lone parents and (b) disabled people; and if he will make a statement. 
Mr. Nicholas Brown: Compulsory work-focused interviews for lone parents and disabled people have been piloted as part of the ONE service. Qualitative research from the evaluation has recently been published.
Lone parents and disabled people have generally reported that these compulsory interviews are a positive experience. We are taking forward the lessons learnt from these programmes in the development of Jobcentre Plus. Jobcentre Plus will provide a new service to benefit claimants of working age, offering help to those looking for work now or in the future. We are opening the door to more independence for those who feel trapped on benefit.
Mr. Willetts: To ask the Secretary of State for Work and Pensions what advice was given to the Rehabilitation Resource Centre at City University, London, regarding the application process for the evaluation of the New Deal for Disabled People. 
Mr. Nicholas Brown [holding answer 10 July 2001]: On 2 March 2001 an invitation seeking expressions of interest in tendering for the evaluation of New Deal for Disabled People was posted on the New Deal website. The website also contained information about the evaluation and about the New Deal for Disabled People.
16 Jul 2001 : Column: 65W
Mr. Cousins: To ask the Secretary of State for Work and Pensions if he will estimate the numbers of pensioners claiming (a) the Minimum Income Guarantee, (b) Housing Benefit, (c) Council Tax Benefit and (d) Attendance Allowance; and how many pensioners who are eligible do not claim these benefits. 
Available information on take-up of benefit can be found in the publication "Income Related BenefitsEstimates of Take Up in 199899", a copy of which is in the Library. Up-to-date information on take-up of Attendance Allowance is not available.
Mr. Burstow: To ask the Secretary of State for Work and Pensions, pursuant to his answer of 5 July 2001, Official Report, column 270W, concerning hospital downrating, if he will estimate the annual cost of abolishing the reduction of state pensions, other contributory benefits and income-related benefits for the first 12 weeks for (a) claimants and (b) pensioners. 
16 Jul 2001 : Column: 66W
to the pension credit consultation document will include both a summary of the responses received and details of the organisations that provided submissions. 
Mr. Watson: To ask the Secretary of State for Work and Pensions when he expects to receive the Occupational Pensions Regulatory Authority's fifth annual report; and if he will make a statement. 
Mr. Darling: I have today placed in the Library copies of the UK National Action Plan on Social Inclusion for 200103, which sets out the Government's policies for implementing the objectives in the fight against social exclusion and the eradication of poverty, agreed at the European Council held in Nice in December 2000. The plan contains information on policies and programmes that are tackling exclusion throughout the UK.
Mr. Gordon Prentice: To ask the Secretary of State for Health how many surgical procedures to remove unwanted tattoos on (a) women and (b) men were carried out by the NHS; and at what cost in each year since 1997. 
Yvette Cooper: The table shows data for in-patient episodes for minor skin procedures, such as for the removal of tattoos and port wine stains, in national health service hospitals in England from 199798 to 19992000. This is the most recent information available. Information on the cost of these episodes is not collected centrally.
Hospital Episode Statistics
16 Jul 2001 : Column: 67W
(3) what guidelines he has issued to health authorities assessing the HER-2 status of women diagnosed with breast cancer; 
(4) what proportion of women diagnosed with breast cancer were assessed for the expression of the HER-2 marker (a) by the NHS and (b) privately in England in (i) 2000 and (ii) 2001; 
(5) what financial support he has provided to cancer centres and units to assess the HER-2 status of women diagnosed with breast cancer; 
(6) what assessment he has made of the implications for treatment of women with breast cancer who overexpress the HER-2 marker; 
(7) what recent discussions he has had with the (a) cancer charities, (b) patient group of organisations, (c) medical profession and (d) pharmaceutical companies regarding HER-2 testing of women diagnosed with breast cancer. 
Yvette Cooper: We do not know how many women are currently tested for the HER-2 marker, either on the national health service or privately. Some research groups working in NHS trusts will measure HER-2 status for research purposes, or prior to entry of patients into clinical trials.
The National Institute for Clinical Excellence (NICE) is currently assessing the clinical and cost-effectiveness of herceptin (a drug that specifically targets the HER-2 protein) and will publish guidance shortly. As part of that appraisal process we expect that NICE will be looking at the cost of HER-2 testing. Charities, patient groups, health professionals and the pharmaceutical industry will all have had the opportunity to submit evidence to NICE during this process.
Yvette Cooper: No assessment has been made of the impact of non-prescription herceptin in women who over express the HER2 marker. The National Institute for Clinical Excellence has been asked to evaluate the clinical and cost effectiveness of herceptin in the treatment of advanced breast cancer.
|Next Section||Index||Home Page|